3349 studies found for:    Open Studies | "Brain Diseases"
Show Display Options
Rank Status Study
21 Unknown  Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain
Condition: Functional Brain Disorders /Neuropathic Pain
Intervention: Device: ExAblate 4000 focused ultrasound brain intervention
22 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
23 Recruiting Study of Selected X-Linked Disorders: Aicardi Syndrome
Conditions: Aicardi Syndrome;   Brain Disorders
Intervention:
24 Recruiting Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders
Conditions: Brain Disorders;   Birth Defects;   Craniofacial Differences
Intervention:
25 Recruiting Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Conditions: Hepatic Encephalopathy;   HE;   Cirrhosis;   Altered Mental Status;   AMS
Interventions: Drug: Lactulose;   Drug: Polyethylene Glycol 3350
26 Recruiting The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
27 Unknown  A Nutritional Approach to Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Other: Nutritional Intervention;   Other: Nutritional  Intervention
28 Recruiting L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Conditions: Cirrhosis of Liver;   Hepatic Encephalopathy
Interventions: Drug: L-ornithine L-aspartate;   Drug: Placebo
29 Recruiting Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
Condition: Hepatic Encephalopathy
Intervention: Biological: Fecal Microbiota Transplant
30 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
31 Recruiting Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Conditions: Hepatic Encephalopathy;   Cirrhosis;   Nonalcoholic Steatohepatitis;   Hepatitis C
Intervention:
32 Unknown  Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Intervention: Dietary Supplement: whole milk vs lactose-free milk
33 Recruiting The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
34 Recruiting Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Conditions: Refractory Ascites;   Hepatic Hydrothorax;   Hepatic Encephalopathy;   Cirrhosis
Interventions: Other: Oral glutamine challenge;   Other: Psychometric Tests
35 Recruiting Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Conditions: Cirrhosis;   Hepatic Encephalopathy
Intervention:
36 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
37 Recruiting Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: rifaximine
38 Not yet recruiting ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3
39 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
40 Recruiting Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Lactulose and rifaximin;   Dietary Supplement: Branched Chain amino acids;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years